北米の注射器・注射針市場見通し(~2021)

◆英語タイトル:North America Syringes and Needles Market Outlook to 2021
◆商品コード:GDMECR0430DB
◆発行会社(調査会社):GlobalData
◆発行日:2016年4月1日
◆ページ数:126
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD6,000 ⇒換算¥666,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD9,000 ⇒換算¥999,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

North America Syringes and Needles Market Outlook to 2021
Summary

GlobalData’s new report, “North America Syringes and Needles Market Outlook to 2021″, provides key market data on the North America Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments – General Syringes and Specialized Syringes.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Syringes and Needles market segments – General Syringes and Specialized Syringes.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Syringes and Needles market.
- Global corporate-level profiles of key companies operating within the North America Syringes and Needles market.
- Key players covered include Becton, Dickinson and Company, Covidien plc, B. Braun Melsungen AG, Nipro Corporation and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Syringes and Needles Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Syringes and Needles Market, North America 10
3.1 Syringes and Needles Market, North America, Revenue ($m), 2007-2021 10
3.2 Syringes and Needles Market, North America, Revenue ($m), 2007-2014 12
3.3 Syringes and Needles Market, North America, Revenue ($m), 2014-2021 14
3.4 Syringes and Needles Market, North America, Volume (Units), 2007-2021 16
3.5 Syringes and Needles Market, North America, Volume (Units), 2007-2014 17
3.6 Syringes and Needles Market, North America, Volume (Units), 2014-2021 19
3.7 Syringes and Needles Market, North America, Company Share by Revenue ($m), 2014 21
4 Syringes and Needles Market, Canada 23
4.1 Syringes and Needles Market, Canada, Revenue ($m), 2007-2014 23
4.2 Syringes and Needles Market, Canada, Revenue ($m), 2014-2021 25
4.3 Syringes and Needles Market, Canada, Volume (Units), 2007-2014 27
4.4 Syringes and Needles Market, Canada, Volume (Units), 2014-2021 29
4.5 Syringes and Needles Market, Canada, Average Price ($), 2007-2021 31
4.6 Syringes and Needles Market, Canada, Distribution Share by Revenue ($m), 2013-2014 32
4.7 Syringes and Needles Market, Canada, Company Share by Revenue ($m), 2014 33
5 Syringes and Needles Market, Mexico 35
5.1 Syringes and Needles Market, Mexico, Revenue ($m), 2007-2014 35
5.2 Syringes and Needles Market, Mexico, Revenue ($m), 2014-2021 37
5.3 Syringes and Needles Market, Mexico, Volume (Units), 2007-2014 39
5.4 Syringes and Needles Market, Mexico, Volume (Units), 2014-2021 41
5.5 Syringes and Needles Market, Mexico, Average Price ($), 2007-2021 43
5.6 Syringes and Needles Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 44
5.7 Syringes and Needles Market, Mexico, Company Share by Revenue ($m), 2014 45
6 Syringes and Needles Market, United States 47
6.1 Syringes and Needles Market, United States, Revenue ($m), 2007-2014 47
6.2 Syringes and Needles Market, United States, Revenue ($m), 2014-2021 49
6.3 Syringes and Needles Market, United States, Volume (Units), 2007-2014 51
6.4 Syringes and Needles Market, United States, Volume (Units), 2014-2021 53
6.5 Syringes and Needles Market, United States, Average Price ($), 2007-2021 55
6.6 Syringes and Needles Market, United States, Distribution Share by Revenue ($m), 2013-2014 56
6.7 Syringes and Needles Market, United States, Company Share by Revenue ($m), 2014 57
7 Overview of Key Companies in North America Syringes and Needles Market 59
7.1 Becton, Dickinson and Company 59
7.1.1 Company Overview 59
7.2 B. Braun Melsungen AG 59
7.2.1 Company Overview 59
7.3 Nipro Corporation 59
7.3.1 Company Overview 59
7.4 Baxter International Inc. 60
7.4.1 Company Overview 60
7.5 Smiths Medical 60
7.5.1 Company Overview 60
7.6 Covidien plc 60
7.6.1 Company Overview 60
8 Syringes and Needles Market Pipeline Products 61
9 Recent Developments 62
9.1 Corporate Communications 62
9.1.1 Feb 25, 2016: Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations 62
9.1.2 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences 62
9.1.3 Aug 25, 2015: Unilife Appoints Harry Hamill to the Board of Directors 63
9.1.4 Aug 03, 2015: Sagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer 63
9.1.5 Aug 01, 2015: SPARC Receives Complete Response Letter from USFDA for Latanoprost NDA 64
9.1.6 Jun 03, 2015: Bristol-Myers Squibb to Present Data from 14 Abstracts on Orencia (abatacept) at the European League Against Rheumatism (EULAR) 2015 Annual Meeting 65
9.1.7 Apr 16, 2015: Sagent Pharmaceuticals Appoints Michael Logerfo as President 68
9.1.8 Apr 16, 2015: Shlomo Yanai Joins Sagent Pharmaceuticals Board of Directors 68
9.1.9 Apr 08, 2015: Unilife Appoints Dr. Richard Beckman as Chief Medical Officer 69
9.1.10 Mar 26, 2015: Sagent Pharmaceuticals Announces Leadership Changes 69
9.2 Financial Announcements 70
9.2.1 Feb 16, 2016: Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results 70
9.2.2 Feb 09, 2016: Unilife Announces Financial Results For the Second Quarter of Fiscal Year 2016 73
9.2.3 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter 73
9.2.4 Nov 09, 2015: Unilife Announces Financial Results For the First Quarter of Fiscal Year 2016 75
9.2.5 Nov 04, 2015: BD Announces Results For 2015 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2016 Guidance 77
9.2.6 Oct 13, 2015: Spring Bank Pharmaceuticals Announces Presentation of Results from Phase I Clinical Trial Supporting the Novel Mechanism of Action of SB 9200 in Patients with Hepatitis C at The Liver Meeting 79
9.2.7 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015 80
9.2.8 Sep 14, 2015: Unilife Corporation Announces Financial Results For the Fourth Quarter and Full Fiscal Year 2015 81
9.2.9 Aug 14, 2015: Retractable Technologies Reports Results as of June 30, 2015 83
9.2.10 Aug 06, 2015: BD Announces Results for 2015 Third Fiscal Quarter and Raises EPS Guidance for Fiscal 2015 85
9.2.11 Aug 04, 2015: Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results 87
9.2.12 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 88
9.2.13 Jul 28, 2015: Centinel Spine Implants Its First STALIF MIDLINE II-Ti Device 89
9.2.14 May 15, 2015: Retractable Technologies Reports Improved Results for the First Quarter 2015 90
9.2.15 May 11, 2015: Unilife Announces Financial Results For Fiscal Year 2015 Third Quarter 91
9.2.16 May 07, 2015: BD Announces Results For 2015 Second Fiscal Quarter 92
9.2.17 May 05, 2015: Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results 93
9.2.18 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results 94
9.2.19 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System 96
9.2.20 Apr 16, 2015: Arch Therapeutics’ AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study 97
9.2.21 Apr 07, 2015: Dualis MedTech and ReliantHeart Partner on Fully Implantable TET System for the HeartAssist5 LVAD 98
9.2.22 Apr 01, 2015: Retractable Technologies Reports Results for the Three and Twelve Months Ended December 31, 2014 99
9.3 Legal And Regulatory 100
9.3.1 Jul 23, 2015: Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 100
9.3.2 May 21, 2015: Retractable Technologies Reports Recognition of Payment 101
9.3.3 May 01, 2015: Hospira Statement On FDA’s Final Biosimilar Guidance Documents 101
9.3.4 Apr 27, 2015: Retractable Technologies Announces Amended Final Judgment and Notice of Appeal 102
9.3.5 Apr 21, 2015: Retractable Technologies Announces U.S. Supreme Court Decision – Denial of Writ of Certiorari 102
9.3.6 Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant 103
9.3.7 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines 103
9.4 Other Significant Developments 104
9.4.1 Mar 14, 2016: Unilife Realigns Business Units and Leadership Team 104
9.4.2 Dec 07, 2015: ARxIUM Selects Additional Distributors of RIVA Automated Compounding System for Asia-Pacific Region 105
9.4.3 Nov 03, 2015: Sigma-Aldrich Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00 106
9.4.4 Oct 20, 2015: ARxIUM Selects Silver Wing Asia-Pacific International Medical Technology Company as its Exclusive Distributor of RIVA Automated Compounding System in Mainland China 107
9.4.5 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes 108
9.4.6 Sep 15, 2015: BD Named 2015 Outstanding Corporate Innovator Winner by Product Development and Management Association 109
9.4.7 May 07, 2015: Sigma-Aldrich Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Quarterly Dividend. 109
9.4.8 May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement 111
9.4.9 Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche 112
9.4.10 Mar 19, 2015: Roche announces global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich 112
9.5 Product News 113
9.5.1 Oct 05, 2015: Galil Medical Launches New Family Of Cryoablation Needles 113
9.5.2 Apr 13, 2015: Cadence Announces New LaserSwiss Capability 113
9.6 Strategy And Business Planning 114
9.6.1 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges 114
9.6.2 Jan 20, 2016: West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems 115
9.6.3 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma 116
9.6.4 Jul 13, 2015: BD Announces Sustainability Goals for 2020 118
9.6.5 Jul 08, 2015: BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 119
9.6.6 May 21, 2015: Cadence Announces Major Expansion of Wisconsin Facility 119
9.6.7 May 18, 2015: Haselmeier Group Announces the Relocation of Haselmeier in the United States 120
9.6.8 May 12, 2015: SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling 120
9.6.9 Apr 17, 2015: Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 121
9.6.10 Apr 06, 2015: Breakout Labs and Becton, Dickinson and Company Partner to Provide Capital and Expertise to Biomedical Startups 122
10 Appendix 123
10.1 Research Methodology 124
10.1.1 Coverage 124
10.1.2 Secondary Research 124
10.1.3 Primary Research 124
10.1.4 Company Share Analysis 125
10.1.5 Distribution Share Analysis 125
10.2 GlobalData Consulting 125
10.3 Contact Us 125
10.4 Disclaimer 126

1.1 List of Tables
Table 1: Syringes and Needles Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 11
Table 2: Syringes and Needles Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 13
Table 3: Syringes and Needles Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 15
Table 4: Syringes and Needles Market, North America, Volume (Units), 2007-2021 16
Table 5: Syringes and Needles Market, North America, Volume (Units), Historic, 2007-2014 18
Table 6: Syringes and Needles Market, North America, Volume (Units), Forecast, 2014-2021 20
Table 7: Syringes and Needles Market, North America, Company Share by Revenue ($m), USD Constant, 2014 22
Table 8: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 24
Table 9: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 10: Syringes and Needles Market, Canada, Volume (Units), Historic, 2007-2014 28
Table 11: Syringes and Needles Market, Canada, Volume (Units), Forecast, 2014-2021 30
Table 12: Syringes and Needles Market, Canada, Average Price ($), Historic, 2007-2014 31
Table 13: Syringes and Needles Market, Canada, Average Price ($), Forecast, 2014-2021 31
Table 14: Syringes and Needles Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 32
Table 15: Syringes and Needles Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 34
Table 16: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 36
Table 17: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 18: Syringes and Needles Market, Mexico, Volume (Units), Historic, 2007-2014 40
Table 19: Syringes and Needles Market, Mexico, Volume (Units), Forecast, 2014-2021 42
Table 20: Syringes and Needles Market, Mexico, Average Price ($), Historic, 2007-2014 43
Table 21: Syringes and Needles Market, Mexico, Average Price ($), Forecast, 2014-2021 43
Table 22: Syringes and Needles Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014 44
Table 23: Syringes and Needles Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014 46
Table 24: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 48
Table 25: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 50
Table 26: Syringes and Needles Market, United States, Volume (Units), Historic, 2007-2014 52
Table 27: Syringes and Needles Market, United States, Volume (Units), Forecast, 2014-2021 54
Table 28: Syringes and Needles Market, United States, Average Price ($), Historic, 2007-2014 55
Table 29: Syringes and Needles Market, United States, Average Price ($), Forecast, 2014-2021 55
Table 30: Syringes and Needles Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 56
Table 31: Syringes and Needles Market, United States, Company Share by Revenue ($m), USD Constant, 2014 58
Table 32: Syringes and Needles Market Pipeline Products 61

1.2 List of Figures
Figure 1: Syringes and Needles Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 10
Figure 2: Syringes and Needles Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 12
Figure 3: Syringes and Needles Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 14
Figure 4: Syringes and Needles Market, North America, Volume (Units), 2007-2021 16
Figure 5: Syringes and Needles Market, North America, Volume (Units), Historic, 2007-2014 17
Figure 6: Syringes and Needles Market, North America, Volume (Units), Forecast, 2014-2021 19
Figure 7: Syringes and Needles Market, North America, Company Share (%) 2014 21
Figure 8: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 23
Figure 9: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 10: Syringes and Needles Market, Canada, Volume (Units), Historic, 2007-2014 27
Figure 11: Syringes and Needles Market, Canada, Volume (Units), Forecast, 2014-2021 29
Figure 12: Syringes and Needles Market, Canada, Company Share (%) 2014 33
Figure 13: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 35
Figure 14: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 15: Syringes and Needles Market, Mexico, Volume (Units), Historic, 2007-2014 39
Figure 16: Syringes and Needles Market, Mexico, Volume (Units), Forecast, 2014-2021 41
Figure 17: Syringes and Needles Market, Mexico, Company Share (%) 2014 45
Figure 18: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 47
Figure 19: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 49
Figure 20: Syringes and Needles Market, United States, Volume (Units), Historic, 2007-2014 51
Figure 21: Syringes and Needles Market, United States, Volume (Units), Forecast, 2014-2021 53
Figure 22: Syringes and Needles Market, United States, Company Share (%) 2014 57

【掲載企業】

Becton, Dickinson and Company
B. Braun Melsungen AG
Nipro Corporation
Baxter International Inc.
Smiths Medical
Covidien plc

★調査レポート[北米の注射器・注射針市場見通し(~2021)]販売に関する免責事項
★調査レポート[北米の注射器・注射針市場見通し(~2021)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆